Log in to save to my catalogue

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro...

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587992

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo

About this item

Full title

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo

Publisher

Greece: D.A. Spandidos

Journal title

Oncology letters, 2017-09, Vol.14 (3), p.3349-3356

Language

English

Formats

Publication information

Publisher

Greece: D.A. Spandidos

More information

Scope and Contents

Contents

Gimeracil or 5-chloro-2,4-dihydroxypyridine (CDHP) enhances the antitumor effects of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase (DPD), which is involved in the degradation of 5-FU. CDHP, as part of a combination therapy, was also reported to exert a radiosensitizing effect. Therefore, CDHP may have underlying mechanisms of...

Alternative Titles

Full title

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587992

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587992

Other Identifiers

ISSN

1792-1074

E-ISSN

1792-1082

DOI

10.3892/ol.2017.6602

How to access this item